LOUANN KENDALL: Open Payments
NPI 1285736082 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 40 payments from 14 companies in 2025. Trend: 2023 $111 · 2024 $1,537 · 2025 $830
Food & beverage: $830
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $294 |
| UCB, Inc. | 3 | $132 |
| Genentech USA, Inc. | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| Eisai Inc. | 2 | $50 |
| Neurelis, Inc. | 2 | $49 |
| Lilly USA, LLC | 2 | $41 |
| Alexion Pharmaceuticals, Inc. | 2 | $37 |
| SK Life Science, Inc. | 1 | $26 |
| EMD Serono, Inc. | 1 | $22 |
Products named: Briviact, BOTOX, QULIPTA, Ocrevus Zunovo, HYQVIA, Leqembi, VALTOCO, AMYVID.
Industry payments across TN — which companies pay providers there.
